Marianne van der Steen Announces the Opening of Hummingbird Biomedical Lab
Marianne van der Steen, Professor of Entrepreneurship in Healthcare at Universiteit Maastricht, shared on LinkedIn:
”Hummingbird Biomedical and Coagulation Profile BV are proud to announce the opening of the new Hummingbird Biomedical Lab -joining other organizations located on the Mayo Clinic Scottsdale campus, a leading destination for complex care.
This is an exciting opportunity to accelerate the growth of Coagulation Profile’s solutions in the U.S.
The company is a global leader in haemostatic profiling, delivers high-precision solutions in thrombosis and haemostasis for both clinical and research settings.
Hummingbird Biomedical accelerates the global expansion of breakthrough therapies and medical technologies through its hub-and-spoke platform, connecting ventures to scalable manufacturing, clinical and market expansion capabilities and strategic funding.
Learn more: Hummingbird Biomedical and Coagulation Profile B.V.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis